United States - English - NLM (National Library of Medicine)

parke-davis div of pfizer inc - phenelzine sulfate (unii: 2681d7p965) (phenelzine - unii:o408n561gf) - phenelzine 15 mg - nardil has been found to be effective in depressed patients clinically characterized as "atypical," "nonendogenous," or "neurotic." these patients often have mixed anxiety and depression and phobic or hypochondriacal features. there is less conclusive evidence of its usefulness with severely depressed patients with endogenous features. nardil should rarely be the first antidepressant drug used. rather, it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions. nardil should not be used in patients who are hypersensitive to the drug or its ingredients, with pheochromocytoma, congestive heart failure, severe renal impairment or renal disease, a history of liver disease, or abnormal liver function tests. the potentiation of sympathomimetic substances and related compounds by mao inhibitors may result in hypertensive crises (see warnings). therefore, patients being treated with nardil should not take sympathomimetic drugs (including amphetamines, co

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenytoin sodium, quantity: 100 mg - capsule, hard - excipient ingredients: gelatin; magnesium stearate; erythrosine; purified talc; titanium dioxide; sunset yellow fcf; carbon black; lactose monohydrate; maize starch; sucrose - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration).

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - phenytoin sodium, quantity: 30 mg - capsule, hard - excipient ingredients: magnesium stearate; purified talc; gelatin; carbon black; titanium dioxide; lactose monohydrate; maize starch; sucrose - dilantin is indicated for the control of grand mal and psychomotor seizures. dilantin will prevent or effectively decrease the incidence and severity of convulsive seizures in a high percentage of cases, with patients exhibiting little tendency to become resistant to its action. besides its effectiveness in controlling seizures, dilantin frequently improves the mental condition and outlook of epileptic patients and there is also increasing evidence that dilantin is valuable in the prevention of seizures occurring during or after neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see dosage and administration).

United States - English - NLM (National Library of Medicine)

parke-davis div of pfizer inc - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin 82.5 mg - lyrica cr is indicated for the management of: efficacy of lyrica cr has not been established for the management of fibromyalgia or as adjunctive therapy for adult patients with partial onset seizures. lyrica cr is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.1, 5.2), adverse reactions (6)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to pregabalin during pregnancy. to provide information regarding the effects of in utero exposure to lyrica cr, physicians are advised to recommend that pregnant patients taking lyrica cr enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. information on the registry can also be found at the website h

United States - English - NLM (National Library of Medicine)

parke-davis div of pfizer inc - pregabalin (unii: 55jg375s6m) (pregabalin - unii:55jg375s6m) - pregabalin 25 mg - lyrica is indicated for: lyrica is contraindicated in patients with known hypersensitivity to pregabalin or any of its components. angioedema and hypersensitivity reactions have occurred in patients receiving pregabalin therapy [see warnings and precautions (5.2)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to lyrica during pregnancy. to provide information regarding the effects of in utero exposure to lyrica, physicians are advised to recommend that pregnant patients taking lyrica enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. information on the registry can also be found at the website http://www.aedpregnancyregistry.org/. risk summary there are no adequate and well-controlled studies with lyrica in pregnant women. however, in animal reproduction studies, increased incidences of fetal structural abnor

United States - English - NLM (National Library of Medicine)

parke-davis div of pfizer inc - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 100 mg - neurontin® is indicated for: neurontin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as neurontin, during pregnancy. encourage women who are taking neurontin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of neurontin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal and visceral abnormalities, and increased embryofetal mortality) when administered to pregnant animals at doses similar to or lower than those used clinically [see data]. in the u.s. general population, the estimated background

United States - English - NLM (National Library of Medicine)

parke-davis - chloramphenicol (unii: 66974fr9q1) (chloramphenicol - unii:66974fr9q1) - ointment - chloramphenicol should be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. bacteriological studies should be performed to determine the causative organisms and their sensitivity to chloramphenicol (see boxed warning). chloromycetin ophthalmic ointment, 1% (chloramphenicol ophthalmic ointment, usp) is indicated for the treatment of surface ocular infections involving the conjunctiva and/or cornea caused by chloramphenicol-susceptible organisms. the particular antiinfective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus streptococcus , including streptococcus pneumoniae escherichia coli haemophilus influenzae klebsiella/enterobacter species moraxella lucunata     (morax-axenfeld bacillus) neisseria species this product does not provide adequate coverage against: pseudomonas aeruginosa serratia marcescens this product is contraindicated in persons sensitive to any of its components.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - mefenamic acid, quantity: 250 mg - capsule, hard - excipient ingredients: gelatin; carbon black; iron oxide yellow; brilliant blue fcf; lactose monohydrate; titanium dioxide - treatment of primary dysmenorrhoea and primary menorrhoea. short-term relief of mild to moderate pain such as dental pain and soft tissue pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

masimo australia pty ltd - 47582 - pulse co-oximeter probe, reusable - a photoelectric component of a pulse co-oximeter that is applied externally to a body part (e.g., a fingertip for adults, the hand or foot for neonates), for the transcutaneous multiwave measurement of carboxy-haemoglobin saturation (spco) and typically several other related parameters such as arterial oxygen saturation (spo2), methaemoglobin saturation (spmet), haemoglobin concentration (sphb), haematocrit, and pulse rate using light detection. the device is re usable.

Australia - English - Department of Health (Therapeutic Goods Administration)

draeger australia pty ltd - 47582 - pulse co-oximeter probe, reusable - the rainbow reusable sensors are intended for "spot check" or continuous non-invasive monitoring of arterial saturation (spo2), arterial carboxyhemoglobin saturation (spco) and other related parameters including arterial methemoglobin (spmet), and pulse rate when used with draeger patient monitors.